QFS-40721-05252 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-26
Dose 1 — Janssen/Johnson & Johnson
2022-01-24
Dose 2 — Moderna
2022-01-25
Registered in v-safe
2022-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · None

Adult check-in
2022-01-31
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2022-02-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-02-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-02-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2022-02-28
Survey response — day 35, dose 2
MedDRA: Cough, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities

Free text: Runny nose, cough

MedDRA releases: 2024-11 · check-in free text available
2022-04-25
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-07-28
Survey response — 6 months, dose 2
MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities

Free text: Covid in June

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-26	Janssen/Johnson & Johnson	No
2	2022-01-24	Moderna	No

Free text

Release 11 — day 35, dose 2

2022-02-28

Symptoms: Runny nose, cough

Release 12 — 6 months, dose 2

2022-07-28

Symptoms: Covid in June

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release